Edward Flynn
What they argued
RecovryAI’s one-line reading of the filing.
Bias and liability concerns; GenAI devices shouldn't be allowed into use until resolved. Does not engage framework.
Themes it raises
3 of the 21 themes in the docket.
Who is accountable when something goes wrongFDA Q21
Equity, access and under-resourced settingsFDA Q3, Q13, Q21
Privacy and protection of patient dataNot asked by the FDA
Read and coded by RecovryAI readers, September 12, 2026. The original submission is linked below. Read the filing on regulations.gov ↗
This filing was submitted by a member of the public. We publish our analysis here and link to the submission rather than reproducing it, and this page is not indexed by search engines. Read the full submission on regulations.gov ↗